NLRP3 and depressive symptom measurement: At the end of the experimental procedure, MDA, GSH, BDNF, IL‐1B, and NLRP3 levels were analyzed in the hippocampus to analyze the physiopathological mechanism of menopause‐related depression and the therapeutic effects of valsartan on these mechanisms.